Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor RECK via down regulation of its target gene, 16/April/2014, 6.40 am

Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor RECK via down regulation of its target gene, 16/April/2014, 6.40 am

Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor RECK via down regulation of its target gene, 16/April/2014, 6.40 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor RECK  via  down regulation of  its target gene, 16/April/2014, 6.41 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing